suggested that liraglutide improved serum lipid profile and hepatic steatosis by inducing autophagy through the adenosine monophosphate activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) pathway [11], which has a key role in autophagy modulation [34]. Here, MTOR is linked to fatty liver disease.